Abortion court battle threatens FDA approval process
Amid a high-stakes court battle over the abortion drug mifepristone, legal experts and pharmaceutical companies are warning a Texas court ruling may impact the approval of almost every drug week, a federal court ruling by District Judge Matthew Kacsmaryk…
Read More